References
- Sieling PA, Modlin RL. Cytokine patterns at the site of mycobacterial infection. Immunobiology 1994; 191: 378–87.
- Haanen JB, de Waal-Malefijt R, Res PC, Kraakman EM, Ottenhoff TH, de-Vries RR, Spits H. Selection of a human T helper type 1-like T cell subset by mycobacteria. J Exp Med 1991; 174: 583–92.
- Yamamura M, Uyemura K, Deans RJ, Weinberg K, Rea TH, Bloom BR, Modlin RL. Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science 1991; 254: 277–9.
- Misra N, Murtaza A, Walker B, Narayan NP, Misra RS, Ramesh V, et al. Cytokine profile of circulating T cells of leprosy patients reflects both indiscriminate and polarized T- helper subsets: T-helper phenotype is stable and uninfluenced by related antigens of Mycobacterium leprae. Immunology 1995; 86: 97–103.
- Gordon J. CD23 and B cell activation. Clin Exp Allergy 1992; 22: 199–204.
- Delespesse G, Suter U, Mossalayi D, Bettler B, Sarfatio M, Sarfati M, et al. Expression, structure and function of the CD23 antigen. Adv Immunol 1991; 49: 149–91.
- Bansal AS, Cochrane S, Haeney MR, Bhavnani M, Pumphrey RSH, Wilson PB. Serum soluble CD23 in conditions with hypogammaglobulinaemia and varying B cell numbers. Clin Exp Immunol 1994; 97: 239–41.
- Bansal AS, Ollier W, Marsh MN, Pumphrey RSH, Wilson PB. Variations in serum sCD23 in conditions with either enhanced humoral or cell-mediated immunity. Immunology 1993; 79: 285–9.
- Ridley DS, Jopling WH. Classification of leprosy according to immunity: a five group system. Int J Lepr 1966; 34: 255–73.
- Bansal AS, Roberts T, Hay EM, Kay R, Pumphrey RSH, Wilson PB. Soluble CD23 levels are elevated in the serum of patients with primary Sjögrens syndrome and SLE. Clin Exp Immunol 1992; 89: 452–5.
- Hagiwara E, Gourley MF, Lee S, Klinman DM. Disease severity in patients with systemic lupus erythematosus correlates with an increased ratio of interleukin-10: interferon-y secreting cells in the peripheral blood. Arth Rheumatism 1996; 39: 379–85.
- Przemioslo RT, Lundin KE, Sollid LM, Nelufer J, Ciclitira PT. Histological changes in small bowel mucosa induced by gliadin sensitive T lymphocytes can be blocked by anti-interferon gamma antibody. Gut 1995; 36: 874–9.
- Kontakou M, Sturgess RP, Przemioslo RT, Limb GA, Nelufer JM, Ciclitira PT. Detection of interferon gamma mRNA in the mucosa of patients with coeliac disease by in situ hybridisation. Gut 1994; 35: 1037–41.
- Nilsen EM, Lundin KE, Krajci P, Scott H, Sollid LM, Brandtzaeg P. Gluten specific, HLA-DQ restricted T cells from coeliac mucosa produce cytokines with Th1 or Th0 profile dominated by interferon gamma. Gut 1995; 37: 766–76.
- Fuss IJ, Neurath M, Boirivant M, Klein JS, de-la Motte C, Strong SA, et al. Disparate CD4 + lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn’s disease LP cells manifest increased secretion of IFN gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J Immunol 1996; 157: 1261–70.
- Noguchi M, Hiwatashi N, Liu Z, Toyota T. Enhanced interferon-gamma production and B7–2 expression in isolated intestinal mononuclear cells from patients with Crohn’s disease. J Gastroenterol 1995; 30 Suppl 8: 52–5.
- Sasaki T, Hiwatashi N, Yamazaki H, Noguchi M, Toypota T. The role of interferon y in the pathogenesis of Crohn’s disease. Gastroenterol Jpn 1992; 27: 29–35.